Author:
Crippa S.,Bittoni A.,Sebastiani E.,Partelli S.,Zanon S.,Lanese A.,Andrikou K.,Muffatti F.,Balzano G.,Reni M.,Cascinu S.,Falconi M.
Subject
Oncology,General Medicine,Surgery
Reference24 articles.
1. Addressing the challenges of pancreatic cancer: future directions for improving outcomes;Hidalgo;Pancreatology,2015
2. Pancreatic cancer;Vincent;Lancet,2011
3. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011
4. A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen);Reni;Cancer Chemother Pharmacol,2012
5. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomized controlled multicentre phase III trial;Reni;Lancet Oncol,2005
Cited by
98 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献